Full video transcriptClick to expand
Auto-generated transcript of @bigpuncustoms's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00What's up everybody? This is officially week four of my TRT therapy today. I started out at
- 0:07308.4 so if you're tracking about I'm down about four pounds right now so averaging a pound a week of loss. That's not bad
- 0:15This week was sadly not as good as the other weeks
- 0:20Apparently I'm having an estrogen issue or we assume right now and I will be getting on an astrozol to block my estrogen because
- 0:27I had emotional breakdown yesterday before my injection to the point I was crying like randomly and I'm like this is so stupid
- 0:35Why so that is not fun?
- 0:38That also said I noticed that on Saturday. I was like yeah, this doesn't feel right something
- 0:43I didn't have the like the go the drive the energy the the stamina everything like
- 0:48Mr. Johnson just it wasn't the same like everything was just off and I was like well
- 0:52Maybe it's just something weird. I'm just kind of like catching up because I've been doing so much extra work with like moving somebody
- 0:59So no, it's pretty sure it's the estrogen now like spiking and it's going up because I feel just as crappy as I did before I
- 1:07Started testosterone so not as fun
- 1:10So yeah, that is what's changing now. I'm gonna be joining or getting on
- 1:16An astrozol, which is getting shipped to me. I'll start that tomorrow. So starting of the week four
- 1:20I started astrozol and see how that changes my mood and everything else
- 1:25I still take the cloned I take it for two days one pill a day before I inject and
- 1:31Other than that nothing else my energy and stamina. Like I said, it wasn't that good this week
- 1:36I did go to the gym a couple times has nice good workouts
- 1:40but
- 1:41Again, it's just afterwards. It was like the recovery like I am still sore from chest that I did now three days ago
- 1:48And I'm just like yeah, the same fun
- 1:50So I definitely want to say if you get on testosterone replacement therapy make sure you watch your estrogen
- 1:56It does affect a lot of men
- 1:57I didn't have the sense of nipples which is a good thing because I don't want to go around being like oh my nipples like
- 2:02But yeah, so I will update next week right now like I said, I've just been losing but a little bit of weight and
- 2:10Felt good and now it's like sliding back down like no no no come back up. I don't need to be like crappy
- 2:16But otherwise
- 2:18You know muscles coming in which was nice like I said when I first let's see so I inject on Wednesday by
- 2:26Thursday Friday. I had a nice good pump. I was like fuck yeah, dude like this is awesome, but now it's like
- 2:32Crap again
- 2:34So if you have any questions comments down below feel free. I will make a video and reply to you
- 2:40otherwise, I hope this video helps somebody out there and
- 2:43Give you some education because yeah week four going into it is not as fun as it was on week one and two
- 2:50But it is what it is and today's date. Oh, yeah, I forgot what today's date is it's August something
- 2:56I don't know 30th whatever Wednesday is of that day
- 3:00So yeah, see you on the next one
TRT week 4 updates: what the science says about early results
Quick answer
The creator is four weeks into testosterone replacement therapy and reporting symptoms consistent with elevated estradiol: emotional lability, reduced libido, fatigue, and poor exercise recovery. His provider appears to have initiated anastrozole as an aromatase inhibitor, and he is concurrently taking clomiphene citrate pre-injection, a combination that falls outside standard TRT protocols and warrants close lab monitoring. Symptom-based estrogen management without serial estradiol testing carries real risk of over-suppression, which produces a nearly identical symptom profile to estrogen excess.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT week 4 updates: what the science says about early results, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
TRT week 4 updates: what the science says about early results should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT week 4 updates: what the science says about early results" from Lou. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is four weeks into testosterone replacement therapy and reporting symptoms consistent with elevated estradiol: emotional lability, reduced libido, fatigue, and poor exercise recovery.
The reason this review is not generic is the source wording and the canonical claim label "trt documenting my journey on trt week 4 update check back next." In this clip, the useful excerpt is: "What's up everybody?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator is four weeks into testosterone replacement therapy and reporting symptoms consistent with elevated estradiol: emotional lability, reduced libido, fatigue, and poor exercise recovery.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is four weeks into testosterone replacement therapy and reporting symptoms consistent with elevated estradiol: emotional lability, reduced libido, fatigue, and poor exercise recovery. His provider appears to have initiated anastrozole as an aromatase inhibitor, and he is concurrently taking clomiphene citrate pre-injection, a combination that falls outside standard TRT protocols and warrants close lab monitoring. Symptom-based estrogen management without serial estradiol testing carries real risk of over-suppression, which produces a nearly identical symptom profile to estrogen excess.
- Estradiol elevation on TRT is real and documented: Ramasamy et al. (2019) confirmed links between high estradiol and sexual dysfunction, mood changes, and fatigue in men on testosterone therapy.
- Symptom-based estrogen management without a sensitive estradiol blood test is unreliable. Low and high estradiol produce nearly identical symptoms, making labs non-optional before starting anastrozole.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Estradiol elevation on TRT is real and documented: Ramasamy et al. (2019) confirmed links between high estradiol and sexual dysfunction, mood changes, and fatigue in men on testosterone therapy.
- Symptom-based estrogen management without a sensitive estradiol blood test is unreliable. Low and high estradiol produce nearly identical symptoms, making labs non-optional before starting anastrozole.
- Finkelstein et al. (2013, NEJM) showed estradiol, not testosterone alone, drives libido in men. Aggressive aromatase inhibition can suppress sexual function rather than restore it.
- Clomiphene plus injectable testosterone is not a standard protocol. The evidence base for clomiphene supports its use as monotherapy for secondary hypogonadism, not as a combination adjunct.
- Four-pound weight loss at week four is likely fluid and glycogen changes, not fat loss. Corona et al. (2016, Sexual Medicine Reviews) found body composition changes from TRT emerge over months, not weeks.
- Gynecomastia risk does not require nipple tenderness as an early warning sign. Glandular tissue changes can develop without early sensitivity, making periodic clinical monitoring important.
- Any anastrozole use should be guided by a prescribing provider using serial bloodwork. Compounded anastrozole is not equivalent to branded formulations in bioavailability, and dose precision directly affects outcomes.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @bigpuncustoms actually say?
Four weeks into testosterone replacement therapy, this creator reported a rough week. He described a spontaneous crying episode the day before his injection, loss of libido and energy, and slow gym recovery. His working theory: estrogen had spiked. His fix: anastrozole, which he called "astrozol," arriving in the mail to block estrogen. He also mentioned taking clomiphene ("cloned") for two days before each injection. He flagged no nipple sensitivity, which he took as a good sign. He's down about four pounds overall, roughly a pound per week.
To his credit, he's not claiming to be a doctor. He's documenting a real experience and explicitly telling viewers to watch their estrogen on TRT. That's a more responsible framing than most TRT content on this platform.
Does the science back this up?
Yes, mostly. Estrogen elevation is a well-documented side effect of exogenous testosterone, and the symptoms he described, mood instability, low libido, fatigue, poor recovery, are consistent with elevated estradiol in men. The research supports his self-diagnosis more than he probably realizes.
Testosterone converts to estradiol via the aromatase enzyme, and this conversion increases with higher testosterone levels and body fat. A 2019 review by Ramasamy et al. in Translational Andrology and Urology confirmed that supraphysiologic estradiol in men correlates with sexual dysfunction, mood changes, and fluid retention. The timing also checks out: estrogen tends to peak in the days before the next injection as testosterone levels taper, which is exactly when he had his breakdown. Anastrozole is a legitimate aromatase inhibitor used clinically in this context, though dosing should always be managed by a prescribing provider, not self-adjusted. His instinct to loop in his provider was the right call.
What did they get wrong (or right)?
He got the core mechanism right. Where it gets murkier is the polypharmacy picture. He's taking testosterone, anastrozole, and clomiphene simultaneously. That's a complex hormonal stack.
Clomiphene on TRT is unusual. Clomiphene citrate is typically used as an alternative to TRT in men with secondary hypogonadism because it stimulates the pituitary to produce LH and FSH, preserving natural testosterone production and fertility. Using it alongside exogenous testosterone is less standard, and the evidence base for that combination is thin. A 2019 study by Krzastek et al. in The Journal of Urology noted clomiphene's utility as monotherapy, not as an adjunct to injectable testosterone. His provider may have a rationale here, but viewers shouldn't assume this is a standard protocol.
He also eyeballed his estrogen issue based on symptoms alone, without confirmed labs. Symptom-based estrogen management without bloodwork is a common mistake in the TRT community. Low estradiol from over-correction with anastrozole produces nearly identical symptoms to high estradiol: fatigue, low libido, mood problems. Without a test, you don't know which direction you're off.
What should you actually know?
Estrogen management on TRT is genuinely complicated, and the TikTok version of it is almost always oversimplified. Here's what the evidence actually says.
- Not every man on TRT needs an aromatase inhibitor. Estradiol plays important roles in male bone density, cardiovascular health, and sexual function. A 2013 study by Finkelstein et al. in the New England Journal of Medicine showed that estradiol, not testosterone alone, is primarily responsible for libido and sexual function in men. Crashing estrogen with anastrozole can make things worse, not better.
- The four-pound weight loss he mentions is real but likely water weight and glycogen in the early weeks. TRT-associated fat loss, if it occurs, typically shows up over months, not weeks, per a 2016 meta-analysis by Corona et al. in Sexual Medicine Reviews.
- Anastrozole prescribed for TRT is typically compounded or used off-label. It is not interchangeable with branded formulations in terms of bioavailability, and dose precision matters here. Any adjustment should be guided by labs, specifically a sensitive estradiol assay, not a serum total estrogen test, which is less accurate for men.
- His instinct to watch for gynecomastia was correct. But absence of nipple tenderness at week four doesn't guarantee it won't develop. Gynecomastia from estrogen elevation can appear weeks into a cycle.
His broader advice, watch your estrogen on TRT, is sound. The execution details are where you need a prescriber in the loop, not a TikTok comment section.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Lou · TikTok creator
6.1K views on this video
Documenting my journey on TRT. Week 4 update! Check back next week for the next update! #trt #testosteronebooster #testosteronelevels #testosteronereplacement #test #testosterone #therapytiktok #therapy #menshealth #men #mensmentalhealth #weightloss #over30 #menwellness #wellnesstips #guythings #guytok #happiness TRT Journey
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about estradiol elevation on trt?
Estradiol elevation on TRT is real and documented: Ramasamy et al. (2019) confirmed links between high estradiol and sexual dysfunction, mood changes, and fatigue in men on testosterone therapy.
What does the video say about symptom-based estrogen management without a sensitive estradiol blood test?
Symptom-based estrogen management without a sensitive estradiol blood test is unreliable. Low and high estradiol produce nearly identical symptoms, making labs non-optional before starting anastrozole.
What does the video say about finkelstein et al. (2013, nejm) showed estradiol, not testosterone alone,?
Finkelstein et al. (2013, NEJM) showed estradiol, not testosterone alone, drives libido in men. Aggressive aromatase inhibition can suppress sexual function rather than restore it.
What does the video say about clomiphene plus injectable testosterone?
Clomiphene plus injectable testosterone is not a standard protocol. The evidence base for clomiphene supports its use as monotherapy for secondary hypogonadism, not as a combination adjunct.
What does the video say about four-pound weight loss at week four?
Four-pound weight loss at week four is likely fluid and glycogen changes, not fat loss. Corona et al. (2016, Sexual Medicine Reviews) found body composition changes from TRT emerge over months, not weeks.
What does the video say about gynecomastia risk does not require nipple tenderness as an early?
Gynecomastia risk does not require nipple tenderness as an early warning sign. Glandular tissue changes can develop without early sensitivity, making periodic clinical monitoring important.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Lou, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.